Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes

SIMPLE SUMMARY: Germline pharmacogenomic variants impact the toxicity of many cancer treatment drugs. Though testing for pharmacogenomic variants prior to initiating systemic cancer treatment is not routine, the Clinical Pharmacogenetics Implementation Consortium recommends dosing modifications for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutchcraft, Megan L., Lin, Nan, Zhang, Shulin, Sears, Catherine, Zacholski, Kyle, Belcher, Elizabeth A., Durbin, Eric B., Villano, John L., Cavnar, Michael J., Arnold, Susanne M., Ueland, Frederick R., Kolesar, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468204/
https://www.ncbi.nlm.nih.gov/pubmed/34572750
http://dx.doi.org/10.3390/cancers13184524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468204/
https://www.ncbi.nlm.nih.gov/pubmed/34572750
http://dx.doi.org/10.3390/cancers13184524

Ejemplares similares